CREDIT SUISSE AG/ - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 51 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$244,0000.0%20,255
+3.8%
0.00%
Q4 2018$244,000
-10.9%
19,505
+5.3%
0.00%
Q3 2018$274,000
-28.1%
18,517
-18.2%
0.00%
Q2 2018$381,000
-26.7%
22,642
-0.4%
0.00%
Q1 2018$520,000
-14.0%
22,731
-2.9%
0.00%
-100.0%
Q4 2017$605,000
+199.5%
23,417
+71.0%
0.00%
Q3 2017$202,000
-59.6%
13,691
-53.3%
0.00%
Q1 2017$500,000
+46.6%
29,327
-11.6%
0.00%
Q4 2016$341,000
-9.8%
33,192
-11.4%
0.00%
Q3 2016$378,000
-3.6%
37,454
+7.3%
0.00%
Q2 2016$392,000
+36.6%
34,894
+65.7%
0.00%
Q1 2016$287,000
+4.4%
21,055
+45.4%
0.00%
Q4 2015$275,000
-61.9%
14,485
-62.3%
0.00%
-100.0%
Q3 2015$721,000
+78.5%
38,415
+41.4%
0.00%
Q2 2015$404,000
-58.1%
27,171
-57.4%
0.00%
-100.0%
Q1 2015$965,000
+193.3%
63,753
+158.5%
0.00%
Q4 2014$329,000
+157.0%
24,659
+142.1%
0.00%
Q3 2014$128,000
-26.4%
10,187
-21.1%
0.00%
Q1 2014$174,00012,9100.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders